THE EFFECT OF A 5HT 2 RECEPTOR ANTAGONIST SARPOGRELATE (MCI-9042) TREATMENT ON PLATELET FUNCTION IN BUERGER'S DISEASE

By Rydzewski A.   Urano T.   Hachiya T.   Kaneko H.   Baba S.   Takada Y.   Takada A.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 445-452

Elsevier

Access to resources Recommend Favorite

Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT 2 antagonist (SR46349).

By Li Hui Y.   Callas D.   Fareed J.   Herbert J.M.  

Thrombosis Research, Vol. 81, Iss. 5, 1996-03 ,pp. : 555-567

Elsevier

Access to resources Recommend Favorite

5-Hydroxytryptamine contracts human uterine artery smooth muscle predominantly via 5-HT2 receptors.

By Karlsson C   Bodelsson G   Bodelsson M   Stjernquist M  

Human Reproduction, Vol. 12, Iss. 2, 1997-02 ,pp. : 361-367

Oxford University Press

Access to resources Recommend Favorite

Inhibition of Arterial Thrombosis by a Peptide Ligand of the Thrombin Receptor

By Pakala R.   Liang C.T.   Benedict C.R.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 89-96

Elsevier

Access to resources Recommend Favorite

Evaluation of the Protective Effects of Histamine and 5-hydroxytryptamine Receptor Antagonists Against the Lethal Toxicity Induced by Oxygen Free Radicals in Rats

By Tripathi Mayur   Jandhyala Bhagavan  

Clinical and Experimental Hypertension, Vol. 28, Iss. 2, 2006-02 ,pp. : 109-119

Informa Healthcare

Access to resources Recommend Favorite